Akoya Biosciences, Inc.

Akoya Biosciences, Inc., operating in the Medical, precision and optical instruments, watches and clocks (33) sector, has established comprehensive climate commitments aligned with science-based targets. The company is committed to reaching net-zero greenhouse gas emissions across its value chain by 2050.

In the near term, Akoya Biosciences aims to reduce its scope 1, 2, and 3 in-use operational greenhouse gas (GHG) emissions by 50% per square metre by 2030, using a 2023 baseline. Furthermore, the company is targeting a 42% reduction in absolute scope 3 GHG emissions from a range of categories including purchased goods and services, fuel- and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, and employee commuting within the same timeframe.

Looking towards the long term, Akoya Biosciences has set an ambitious goal to reduce scope 1, 2, and 3 in-use operational GHG emissions by 95.4% per square metre by 2050. Additionally, its scope 3 GHG emissions from purchased goods and services and capital goods are targeted for a 97% reduction per square metre by 2050. The company also aims for a 99.6% reduction in absolute scope 3 GHG emissions from specific categories, including purchased goods and services, fuel- and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, and employee commuting by 2050.

No absolute emissions data in kg CO2e for Akoya Biosciences, Inc. was available for the most recent reporting year.